1. Home
  2. CULP vs XLO Comparison

CULP vs XLO Comparison

Compare CULP & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$2.77

Market Cap

43.8M

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.45

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
XLO
Founded
1972
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
39.4M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
CULP
XLO
Price
$2.77
$8.45
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$28.00
AVG Volume (30 Days)
32.6K
264.1K
Earning Date
03-11-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$213,237,000.00
$43,766,000.00
Revenue This Year
N/A
$88.66
Revenue Next Year
$8.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
589.88
52 Week Low
$2.70
$0.46
52 Week High
$5.20
$9.25

Technical Indicators

Market Signals
Indicator
CULP
XLO
Relative Strength Index (RSI) 31.67 88.35
Support Level $2.73 $0.63
Resistance Level $3.60 N/A
Average True Range (ATR) 0.20 0.49
MACD -0.00 0.45
Stochastic Oscillator 16.22 90.50

Price Performance

Historical Comparison
CULP
XLO

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: